4-amino-1,8-naphthalimide has been researched along with Brain Ischemia in 1 studies
4-amino-1,8-naphthalimide: inhibits ADP-ribosylation; sometimes abreviated as 4-AN;
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kabra, DG | 1 |
| Thiyagarajan, M | 1 |
| Kaul, CL | 1 |
| Sharma, SS | 1 |
1 other study available for 4-amino-1,8-naphthalimide and Brain Ischemia
| Article | Year |
|---|---|
Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Topics: 1-Naphthylamine; Animals; Brain Chemistry; Brain Ischemia; Enzyme Inhibitors; In Situ Nick-End Label | 2004 |